News by Tag: Cancer Prevalence
Rituxan/Mabthera to Maintain the Top Position in Cancer mAbs
March 21, 2012
Despite the entry of biosimilars and stiff competition from other mAbs, Rituxan is likely to maintain its leading position.
March 21, 2012
Despite the entry of biosimilars and stiff competition from other mAbs, Rituxan is likely to maintain its leading position.